Common Stock, Shares, Outstanding of Denali Therapeutics Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Denali Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Denali Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 156,182,177, a 8.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Denali Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 156,182,177 +11,961,191 +8.3% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 146,625,722 +2,785,693 +1.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 145,685,442 +2,561,860 +1.8% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 145,251,258 +2,738,402 +1.9% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 144,220,986 +5,835,488 +4.2% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 143,840,029 +5,788,231 +4.2% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 143,123,582 +5,760,894 +4.2% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 142,512,856 +5,771,229 +4.2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 138,385,498 +2,419,580 +1.8% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 138,051,798 +14,255,360 +12% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 137,362,688 +14,205,410 +12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 136,741,627 +13,883,719 +11% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 135,965,918 +13,682,613 +11% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 123,796,438 +1,785,287 +1.5% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 123,157,278 +1,625,326 +1.3% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 122,857,908 +1,710,476 +1.4% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 122,283,305 +1,751,972 +1.5% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 122,011,151 +2,215,935 +1.8% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 121,531,952 +15,634,080 +15% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 121,147,432 +15,606,089 +15% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 120,531,333 +24,341,398 +25% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 119,795,216 +23,807,609 +25% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 105,897,872 +10,240,976 +11% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 105,541,343 +10,283,638 +11% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 96,189,935 +1,527,500 +1.6% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 95,987,607 +2,013,860 +2.1% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 95,656,896 +2,335,151 +2.5% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 95,257,705 +2,668,716 +2.9% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 94,662,435 +7,182,073 +8.2% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 93,973,747 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 93,321,745 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 92,588,989 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 87,480,362 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.